Dr. Bazhenova on Potential Impact of Immunotherapy in Non-Driver NSCLC

September 1, 2017
Lyudmila A. Bazhenova, MD
Lyudmila A. Bazhenova, MD

Volume 1, Issue 1

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses what potential impact immunotherapy agents could have on outcomes for patients with non-driver non–small cell lung cancer.